Global Drug Discovery Technologies Market Projected to Reach 197 Billion by 2029
ILMN Stock | USD 135.21 0.22 0.16% |
About 50% of Illumina's investors are presently thinking to get in. The analysis of overall sentiment of trading Illumina stock suggests that some investors are interested at this time. Illumina's investing sentiment overview a quick insight into current market opportunities from investing in Illumina. Many technical investors use Illumina stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Illumina |
According to the latest study from BCC Research, the market for Drug Discovery Technologies is expected to grow from 111.9 billion in 2024 to 197.0 billion by the end of 2029, at a compound annual growth rate of 12.0 percent during the forecast period of 2024 to 2029.
Read at finance.yahoo.com
Illumina Current Investor Sentiment
Panic Vs Confidence
50
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Illumina's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Illumina.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Illumina Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Illumina can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Illumina Fundamental Analysis
We analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Illumina is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Illumina Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Illumina stock to make a market-neutral strategy. Peer analysis of Illumina could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics with similar companies.
Peers
Illumina Related Equities
CDNA | Caredx | 2.34 | ||||
TWST | Twist Bioscience | 1.62 | ||||
CSTL | Castle Biosciences | 0.87 | ||||
NTRA | Natera | 0.32 | ||||
GH | Guardant Health | 0.32 | ||||
BNR | Burning Rock | 1.22 | ||||
SERA | Sera Prognostics | 7.56 | ||||
DRIO | DarioHealth Corp | 12.50 |
Check out Illumina Hype Analysis, Illumina Correlation and Illumina Performance. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.98) | Revenue Per Share 27.654 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0262 |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.